Beth C. Seidenberg, Director at Kyverna Therapeutics, Inc. (KYTX), bought 266,666 shares at $7.50 ($2.0M) on 2025-12-18, disclosed to the SEC on 2025-12-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.50 | 133,333 | $1000K | 50.0% |
| 2 | $7.50 | 133,333 | $1000K | 50.0% |
| Total | $7.50 avg | 266,666 | $2.0M | 100% |
| Filing → |
| SGMT | BUY | 2023-07-20 | $750K | — | Filing → |
| SLRN | BUY | 2023-05-11 | $23.6M | — | Filing → |
| VERA | BUY | 2023-04-03 | $17K | — | Filing → |